These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31928993)

  • 1. Headway and hurdles in non-alcoholic fatty liver disease.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):93. PubMed ID: 31928993
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease.
    Filipović B; Forbes A; Tepeš B; Dumitraşcu DL
    Can J Gastroenterol Hepatol; 2018; 2018():2097435. PubMed ID: 30155450
    [No Abstract]   [Full Text] [Related]  

  • 3. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ
    Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183
    [No Abstract]   [Full Text] [Related]  

  • 4. [Non-alcoholic fatty liver: position document of the Catalan Society of Gastroenterology].
    Caballería L; Saló J; Berzigotti A; Planas R; Vila C; Huertas C; Torres M; Torán P; Caballería J;
    Gastroenterol Hepatol; 2014; 37(6):372-83. PubMed ID: 24746904
    [No Abstract]   [Full Text] [Related]  

  • 5. [Non-alcoholic fatty liver disease (NAFLD)].
    Rau M; Weiss J; Geier A
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease: a new epidemic in children.
    Ciocca M; Ramonet M; Álvarez F
    Arch Argent Pediatr; 2016 Dec; 114(6):563-569. PubMed ID: 27869416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 8. A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.
    Temple JL; Cordero P; Li J; Nguyen V; Oben JA
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease: A poorly known pandemic.
    Augustin S; Graupera I; Caballeria J;
    Med Clin (Barc); 2017 Dec; 149(12):542-548. PubMed ID: 28751080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-alcoholic fatty liver disease in children and adolescents].
    Björklund J; Laursen TL; Kazankov K; Thomsen KL; Hamilton-Dutoit S; Stenbøg E; Grønbæk H
    Ugeskr Laeger; 2017 Jul; 179(27):. PubMed ID: 28689548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease.
    Maurice J; Manousou P
    Clin Med (Lond); 2018 Jun; 18(3):245-250. PubMed ID: 29858436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease: A Silent Epidemic.
    Sivell C
    Gastroenterol Nurs; 2019; 42(5):428-434. PubMed ID: 31574071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    ; LaBrecque DR; Abbas Z; Anania F; Ferenci P; Khan AG; Goh KL; Hamid SS; Isakov V; Lizarzabal M; Peñaranda MM; Ramos JF; Sarin S; Stimac D; Thomson AB; Umar M; Krabshuis J; LeMair A;
    J Clin Gastroenterol; 2014 Jul; 48(6):467-73. PubMed ID: 24921212
    [No Abstract]   [Full Text] [Related]  

  • 14. Editors' Introduction to the NAFLD and NASH Special Issue.
    Fuchs M; Schnabl B
    Dig Dis Sci; 2016 May; 61(5):1211-3. PubMed ID: 27068170
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of patients with non-alcoholic steatohepatitis (NASH) in real life.
    Serfaty L
    Liver Int; 2018 Feb; 38 Suppl 1():52-55. PubMed ID: 29427486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality.
    Athyros VG; Doumas M
    Curr Vasc Pharmacol; 2018; 16(3):206-208. PubMed ID: 29598814
    [No Abstract]   [Full Text] [Related]  

  • 17. [[113th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Diagnosis and Management of Non-alcoholic Fatty Liver Diseases and Non-alcoholic Steatohepatitis: Current Concepts].
    Hashimoto E
    Nihon Naika Gakkai Zasshi; 2016 Sep; 105(9):1753-60. PubMed ID: 30169948
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.
    Middleton JP; Wiener RC; Barnes BH; Gurka MJ; DeBoer MD
    Clin Pediatr (Phila); 2014 Dec; 53(14):1318-25. PubMed ID: 24477713
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic.
    Bernstein DE
    Clin Liver Dis; 2018 Feb; 22(1):xiii-xiv. PubMed ID: 29128064
    [No Abstract]   [Full Text] [Related]  

  • 20. Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Mathurin P; Nagy LA
    Gastroenterology; 2016 Jun; 150(8):1695-7. PubMed ID: 27155520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.